Valuation (22%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -15.41 | -16.22 |
PEG Ratio (TTM) | 0.49 | -1.41 |
P/S Ratio (TTM) | 2,231.32 | 48.82 |
P/B Ratio (TTM) | 3.31 | 21.13 |
P/FCF Ratio (TTM) | -17.43 | 9.38 |
Price to 5YR AVG Earnings Ratio | N/A | -0.21 |
Price to 5YR AVG FCF Ratio | N/A | -7.10 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -20.61% | -3.10% |
ROE (TTM) | -27.13% | 24.21% |
Net Profit Margin (TTM) | -16,110.76% | -1,069.78% |
ROIC 5YR AVG | N/A | 16.50% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -5.92% | -137.40% | N/A |
Revenue | -25.00% | N/A | N/A |
Net Income | -12.45% | -136.02% | N/A |
Cash Flow | -16.65% | -171.39% | N/A |
Health (61%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 36.46 | 5.75 |
Quick Ratio (TTM) | 36.46 | 5.47 |
D/E Ratio (TTM) | 0.02 | -15.13 |
Interest Coverage (TTM) | -38.90 | 3.59 |
Piotroski F-Score | 1 | 5 |
Altman Z-Score | 40.73 | 13.47 |
LTL to 5YR AVG FCF | N/A | 0.20 |
Shares Outstanding Growth 5YR AVG | N/A | 118.86% |